C8ORF41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.377000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.852200E-01
Normal-vs-Stage2
4.214400E-01
Normal-vs-Stage3
2.861800E-01
Normal-vs-Stage4
9.815600E-01
Stage1-vs-Stage2
7.767600E-01
Stage1-vs-Stage3
4.099600E-01
Stage1-vs-Stage4
5.131800E-01
Stage2-vs-Stage3
3.949600E-01
Stage2-vs-Stage4
3.436600E-01
Stage3-vs-Stage4
2.803400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.157200E-01
Normal-vs-AfricanAmerican
6.415600E-01
Normal-vs-Asian
5.104200E-01
Caucasian-vs-AfricanAmerican
6.044400E-01
Caucasian-vs-Asian
7.176000E-01
AfricanAmerican-vs-Asian
8.211600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.430000E-01
Normal-vs-Female
4.080600E-01
Male-vs-Female
8.128600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.466180E-01
Normal-vs-Age(41-60Yrs)
6.337400E-01
Normal-vs-Age(61-80Yrs)
3.939000E-01
Normal-vs-Age(81-100Yrs)
1.445800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.123400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.400800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.212200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.182200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.951500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.889350E-01
Normal-vs-Daily Drinker
1.253380E-01
Normal-vs-Weekly Drinker
5.844600E-01
Normal-vs-Occasional Drinker
5.888800E-01
Normal-vs-Social Drinker
9.266200E-01
Non Drinker-vs-Daily Drinker
7.481400E-01
Non Drinker-vs-Weekly Drinker
2.248000E-01
Non Drinker-vs-Occasional Drinker
9.477900E-02
Non Drinker-vs-Social Drinker
1.339660E-02
Daily Drinker-vs-Weekly Drinker
1.522030E-01
Daily Drinker-vs-Occasional Drinker
5.383600E-02
Daily Drinker-vs-Social Drinker
8.520800E-03
Weekly Drinker-vs-Occasional Drinker
8.303200E-01
Weekly Drinker-vs-Social Drinker
3.031400E-01
Occasional Drinker-vs-Social Drinker
3.158600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.824770E-01
Normal-vs-Grade 2
5.050600E-01
Normal-vs-Grade 3
6.036300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.240400E-01
Grade 1-vs-Grade 3
2.374800E-01
Grade 1-vs-Grade 4
1.824770E-01
Grade 2-vs-Grade 3
6.447400E-01
Grade 2-vs-Grade 4
5.050600E-01
Grade 3-vs-Grade 4
6.036300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.465200E-01
Normal-vs-NonDiabetic
4.505400E-01
Diabetic-vs-NonDiabetic
2.368800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.110600E-01
Normal-vs-NoPancreatitis
4.077600E-01
Pancreatitis-vs-NoPancreatitis
7.208600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.608600E-01
Normal-vs-N1
4.079600E-01
N0-vs-N1
4.490400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.749200E-01
Normal-vs-TP53-NonMutant
5.950000E-01
TP53-Mutant-vs-TP53-NonMutant
4.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
